Axitinib



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 23.7%
Metastatic Renal Cell Carcinoma 12.9%
Pain 6.1%
Nausea 5.4%
Prophylaxis 5.1%
Renal Cell Carcinoma 5.1%
Diarrhoea 4.8%
Hypothyroidism 4.6%
Constipation 4.1%
Supplementation Therapy 3.8%
Diabetes Mellitus 3.5%
Metastatic Malignant Melanoma 3.1%
Gastrooesophageal Reflux Disease 2.8%
Hepatic Neoplasm Malignant 2.6%
Depression 2.4%
Insomnia 2.1%
Abdominal Pain 2.0%
Asthma 2.0%
Back Pain 2.0%
Colorectal Cancer Metastatic 2.0%
Death 14.1%
Renal Failure Acute 6.7%
Cerebral Ischaemia 5.9%
Hypertension 5.9%
Pneumonia 5.9%
Angina Pectoris 5.2%
Circulatory Collapse 5.2%
Renal Failure 5.2%
Convulsion 4.4%
Fatigue 4.4%
Gastritis 4.4%
Hyperbilirubinaemia 4.4%
Cardio-respiratory Arrest 3.7%
Chest Pain 3.7%
Diverticulum Intestinal Haemorrhagic 3.7%
Dyspnoea 3.7%
Encephalopathy 3.7%
Hepatic Encephalopathy 3.7%
Cerebrovascular Insufficiency 3.0%
Coma Hepatic 3.0%
Secondary
Hypertension 12.1%
Metastatic Renal Cell Carcinoma 10.4%
Pain 8.3%
Colorectal Cancer 7.0%
Drug Use For Unknown Indication 7.0%
Non-small Cell Lung Cancer 6.8%
Colorectal Cancer Metastatic 6.6%
Constipation 6.6%
Product Used For Unknown Indication 5.2%
Gastric Cancer 4.4%
Hypothyroidism 3.8%
Renal Cell Carcinoma 3.5%
Diarrhoea 3.2%
Nausea 3.0%
Pyrexia 2.8%
Abdominal Pain 2.2%
Insomnia 2.0%
Colon Cancer 1.9%
Prophylaxis 1.7%
Anxiety 1.6%
Vomiting 12.6%
Diarrhoea 12.1%
Diverticulum Intestinal Haemorrhagic 11.0%
Fatigue 4.9%
Pneumonia 4.9%
Pyrexia 4.9%
Hypertension 4.4%
Hypovolaemia 4.4%
Nervous System Disorder 3.8%
Renal Failure Acute 3.8%
White Blood Cell Count Increased 3.8%
Cerebrovascular Insufficiency 3.3%
Dyspnoea 3.3%
Gastrointestinal Disorder 3.3%
Hepatic Encephalopathy 3.3%
Otosalpingitis 3.3%
Pulmonary Embolism 3.3%
Subileus 3.3%
Thrombocytopenia 3.3%
Abdominal Pain 2.7%
Concomitant
Metastatic Renal Cell Carcinoma 32.5%
Renal Cell Carcinoma 14.5%
Depression 11.1%
Pain 6.8%
Insomnia 3.4%
Neuroendocrine Carcinoma Metastatic 3.4%
Anxiety 2.6%
Metastases To Bone 2.6%
Nausea 2.6%
Neoplasm 2.6%
Vomiting 2.6%
Abdominal Pain Upper 1.7%
Cardiac Failure Chronic 1.7%
Fatigue 1.7%
Flatulence 1.7%
Hyperuricaemia 1.7%
Metastatic Pain 1.7%
Product Used For Unknown Indication 1.7%
Renal Cancer Metastatic 1.7%
Ventricular Extrasystoles 1.7%
Delirium 30.8%
Vomiting 10.3%
Anorectal Infection 5.1%
Fatigue 5.1%
Gamma-glutamyltransferase Increased 5.1%
Somnolence 5.1%
Weight Decreased 5.1%
C-reactive Protein Increased 2.6%
Eosinophil Count Increased 2.6%
Hypertensive Crisis 2.6%
Lymphopenia 2.6%
Malignant Neoplasm Progression 2.6%
Neutropenia 2.6%
Off Label Use 2.6%
Osteonecrosis Of Jaw 2.6%
Pneumonitis 2.6%
Psychomotor Skills Impaired 2.6%
Rash 2.6%
Staphylococcal Infection 2.6%
Swelling 2.6%
Interacting
Pancreatic Carcinoma 57.1%
Atrial Fibrillation 42.9%
Rectal Haemorrhage 50.0%
Small Intestinal Obstruction 50.0%